Plant stanol ester
Plant stanol ester has been studied in 2 papers since 2001: 2 trials in people; 1 in the past year. The newest paper, Nov 24, 2025: “The effects of three different daily plant stanol ester intakes on influenza vaccination responses: a double-blind, randomized, placebo-controlled intervention study in older adults”.
See all 2 papers on plant stanol ester
At a glance
The findings reach people, from one lab or study. 1 lab in 1 country; 6 trials, none about aging.
“Daily consumption of 2, 3 or 4 g of plant stanols provided as fatty-acid esters, did not improve vaccination responses following annual influenza vaccination in men and women aged 60 years or older.”
None of its findings points the other way.
- 1 lab in 1 country
- 6 trials, none about aging
- Human trial2
Studies in people
2 studies gave plant stanol ester to people and measured what changed.
| What changed | Design | People | Source |
|---|---|---|---|
no change: Has no effect on immune response down: Decreases LDL cholesterol | Randomized trialapproximately 14 days prior to vaccination until 4 weeks post-vaccination | 128 peopleBoth59-87 yearsOlder adults; following influenza vaccination | Food & function, Nov 24, 2025 |
down: Decreases plasma ubiquinol-10-12.3% ± 18.9%; -0.14 microg/mL versus control no change: Has no effect on LDL-cholesterol-standardized ubiquinol-10 | Randomized trial8 weeks | 36 peopleNonhypercholesterolemic subjects | Metabolism: clinical and experimental, May 1, 2001 |
What did studies of plant stanol ester find?
4Studies of plant stanol ester measured 4 outcomes, among them LDL cholesterol, immune response and LDL-cholesterol-standardized ubiquinol-10.
LDL cholesterol
downin humans1
1 study
LDL cholesterol
downin humans1
Plant stanol ester decreases LDL cholesterol in humans.
“Serum LDL-cholesterol concentrations decreased significantly in the 4 g d−1 and 3 g d−1 groups compared with control.”
Human trialfatty-acid estersserum3 or 4 g d−1approximately 14 days prior to vaccination until 4 weeks post-vaccinationn = 128
Food & function
Immune response
no changein humans1
1 study
Immune response
no changein humans1
Plant stanol ester showed no clear effect on immune response in humans following influenza vaccination.
“Daily consumption of 2, 3 or 4 g of plant stanols provided as fatty-acid esters, did not improve vaccination responses following annual influenza vaccination in men and women aged 60 years or older.”
Human trialfollowing influenza vaccinationfatty-acid esters2, 3 or 4 g d−1approximately 14 days prior to vaccination until 4 weeks post-vaccinationn = 128
Food & function
LDL-cholesterol-standardized ubiquinol-10
no changein humans1
1 study
LDL-cholesterol-standardized ubiquinol-10
no changein humans1
Plant stanol ester showed no clear effect on LDL-cholesterol-standardized ubiquinol-10 in humans (nonhypercholesterolemic subjects).
“Changes in LDL-cholesterol-standardized ubiquinol-10 concentrations were not significantly changed.”
Human trialnonhypercholesterolemic subjects8 weeks
Metabolism: clinical and experimental
Plasma ubiquinol-10
downin humans1
1 study
Plasma ubiquinol-10
downin humans1
Plant stanol ester decreases plasma ubiquinol-10 in humans (nonhypercholesterolemic subjects; compared with control products) (-12.3% ± 18.9%; -0.14 microg/mL versus control).
“absolute plasma ubiquinol-10 concentrations were lowered by 12.3% +/- 18.9%”
Human trialnonhypercholesterolemic subjects; compared with control productsvegetable oil-based stanol esters in margarine and shortening2.6 g sitostanol plus 1.2 g campestanol daily8 weeksn = 36
Metabolism: clinical and experimental
Has plant stanol ester been tested in people?
0 of 6 about agingYes: 2 trials in people have been published, and 6 trials are registered.
In trials
No phaseCompleted4 trials
No phaseCompleted4 trials
Hyperlipidemias
No phaseCompleted4 trials